|Day Low/High||95.71 / 98.41|
|52 Wk Low/High||78.97 / 104.82|
If the market comes in further, we are ready to take advantage of opportunities in select names.
Jim discusses Gary Cohn's resignation, Friday's job report, and Danaher's preannounced Q1 earnings.
The Boston-based company nominated Lawrence Culp Jr., Thomas Horton and Leslie Seidman.
Honeywell fits what we are looking to buy in this market -- quality names that reported strong quarters and are now trading at a discount.
Jim discusses our trades from this morning, earnings from Danaher and Nucor, and the JPMorgan-Berkshire Hathaway-Amazon healthcare deal.
Quarterly numbers driven by growth in life sciences and diagnostics businesses.
You might actually be grateful that stocks took one on the jaw on Monday.
The Dow is looking at its second consecutive triple-digit decline on Tuesday, Thomson Reuters confirms it's in talks to sell a stake in its financial and risk business, and Jamie Dimon says he'll stay at JPMorgan Chase for five more years.
Jim discusses GE, Comcast, Illinois Tool Works, and Abbott Labs, all of which reported earnings Wednesday morning.
Could Danaher be interested in GE's Life Sciences business?
Jim discusses our outlook on Allergan, JPMorgan's investment plan, Microsoft, Constellation Brands, and more!
In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.
It's hard to understand the magnitude of the change.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.